| Next-generation sequencing: advances and applications in cancer diagnosis S Serratì, S De Summa, B Pilato, D Petriella, R Lacalamita, S Tommasi, ... OncoTargets and therapy, 7355-7365, 2016 | 201 | 2016 |
| Matrix metalloproteinase 12–dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis S D'Alessio, G Fibbi, M Cinelli, S Guiducci, A Del Rosso, F Margheri, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 152 | 2004 |
| The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation MD Rosso, F Margheri, S Serratì, A Chillà, A Laurenzana, G Fibbi Current pharmaceutical design 17 (19), 1924-1943, 2011 | 115 | 2011 |
| The plasminogen activation system in inflammation M Del Rosso, G Fibbi, M Pucci, F Margheri, S Serrati Front Biosci 13 (13), 4667-4686, 2008 | 89 | 2008 |
| Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases F Margheri, S D'alessio, S Serrati, M Pucci, F Annunziato, L Cosmi, ... Gene Therapy 12 (8), 702-714, 2005 | 88 | 2005 |
| Endothelial progenitor cell–dependent angiogenesis requires localization of the full-length form of uPAR in caveolae F Margheri, A Chilla, A Laurenzana, S Serratì, B Mazzanti, R Saccardi, ... Blood, The Journal of the American Society of Hematology 118 (13), 3743-3755, 2011 | 83 | 2011 |
| CAFs and TGF-β signaling activation by mast cells contribute to resistance to gemcitabine/nabpaclitaxel in pancreatic cancer L Porcelli, RM Iacobazzi, R Di Fonte, S Serratì, A Intini, AG Solimando, ... Cancers 11 (3), 330, 2019 | 81 | 2019 |
| Domain 1 of the urokinase‐type plasminogen activator receptor is required for its morphologic and functional, β2 integrin–mediated connection with actin cytoskeleton in human … F Margheri, M Manetti, S Serratì, D Nosi, M Pucci, M Matucci‐Cerinic, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 79 | 2006 |
| The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis B Giusti, S Serratì, F Margheri, L Papucci, L Rossi, F Poggi, A Magi, ... Arthritis & Rheumatism 52 (11), 3618-3628, 2005 | 76 | 2005 |
| TGFβ1 antagonistic peptides inhibit TGFβ1-dependent angiogenesis S Serratì, F Margheri, M Pucci, AR Cantelmo, R Cammarota, J Dotor, ... Biochemical pharmacology 77 (5), 813-825, 2009 | 72 | 2009 |
| Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma S Serratì, M Guida, R Di Fonte, S De Summa, S Strippoli, RM Iacobazzi, ... Molecular Cancer 21 (1), 20, 2022 | 68 | 2022 |
| A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients B Giusti, G Fibbi, F Margheri, S Serratì, L Rossi, F Poggi, I Lapini, A Magi, ... Arthritis research & therapy 8, 1-17, 2006 | 64 | 2006 |
| Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain–loss of function of pentraxin 3 and matrix metalloproteinase 12 F Margheri, S Serratì, A Lapucci, A Chilla, L Bazzichi, S Bombardieri, ... Arthritis & Rheumatism 62 (8), 2488-2498, 2010 | 58 | 2010 |
| Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β–dependent … S Serratì, A Chillà, A Laurenzana, F Margheri, E Giannoni, L Magnelli, ... Arthritis & Rheumatism 65 (1), 258-269, 2013 | 52 | 2013 |
| Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP‐12‐dependent cleavage of the endothelial cell urokinase receptor S Serrati, M Cinelli, F Margheri, S Guiducci, A Del Rosso, M Pucci, G Fibbi, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 52 | 2006 |
| uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1, 2 signaling in endothelial cells A Biagioni, A Laurenzana, B Menicacci, S Peppicelli, E Andreucci, ... Cellular and Molecular Life Sciences 78, 3057-3072, 2021 | 51 | 2021 |
| Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR‐4‐dependent up‐regulation of urokinase‐type plasminogen activator … S Serrati, F Margheri, G Fibbi, G Di Cara, L Minafra, I Pucci‐Minafra, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 51 | 2008 |
| Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice F Margheri, S Serratì, A Lapucci, C Anastasia, B Giusti, M Pucci, E Torre, ... Neoplasia 11 (10), 1106-1115, 2009 | 46 | 2009 |
| GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides F Margheri, N Schiavone, L Papucci, L Magnelli, S Serratì, A Chilla, ... PLoS One 7 (11), e50342, 2012 | 37 | 2012 |
| Challenges and opportunities of microRNAs in lymphomas G De Tullio, V De Fazio, N Sgherza, C Minoia, S Serratì, F Merchionne, ... Molecules 19 (9), 14723-14781, 2014 | 35 | 2014 |
Mario Del RossoBestätigte E-Mail-Adresse bei unifi.it
